Merck & Co., Inc. (NYSE:MRK) Files An 8-K Other Events

ME Staff 8-k
-
0

Merck & Co., Inc. (NYSE:MRK) Files An 8-K Other Events
Item 8.01. Other Events.

Exhibit

Number

Description

99.1

Press release issued November 6, 2017, regarding tender offer launch.


Merck & Co., Inc. Exhibit
EX-99.1 2 ex99.htm   Exhibit 99.1     News Release ____________________________________________________________________________________ Merck Announces Any and All Tender Offers Release Date: Monday,…
To view the full exhibit click here

About Merck & Co., Inc. (NYSE:MRK)

Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products, which it markets directly and through its joint ventures. It operates through one segment, Pharmaceutical. The Company’s Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers. The Animal Health segment discovers, develops, manufactures and markets animal health products, including vaccines. The Company’s animal health products are sold to veterinarians, distributors and animal producers.

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

© Market Exclusive 2019